<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA Surg</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Surg</journal-id><journal-id journal-id-type="pmc-domain-id">3211</journal-id><journal-id journal-id-type="pmc-domain">jamasd</journal-id><journal-title-group><journal-title>JAMA Surgery</journal-title></journal-title-group><issn pub-type="ppub">2168-6254</issn><issn pub-type="epub">2168-6262</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>JAMA Network</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10267849</article-id><article-id pub-id-type="pmcid-ver">PMC10267849.1</article-id><article-id pub-id-type="pmcaid">10267849</article-id><article-id pub-id-type="pmcaiid">10267849</article-id><article-id pub-id-type="pmid">37314800</article-id><article-id pub-id-type="doi">10.1001/jamasurg.2023.2009</article-id><article-id pub-id-type="publisher-id">soi230031</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="domain" specific-use="print"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group><subj-group subj-group-type="online-first"><subject>Online First</subject></subj-group></article-categories><title-group><article-title>Association of Intraoperative Opioid Administration With Postoperative Pain and Opioid Use</article-title><alt-title alt-title-type="headline">Association of Intraoperative Opioid Administration With Postoperative Pain and Opioid Use</alt-title><alt-title alt-title-type="running-head">Association of Intraoperative Opioid Administration With Postoperative Pain and Opioid Use</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Santa Cruz Mercado</surname><given-names initials="LA">Laura A.</given-names></name><degrees>MD</degrees><xref rid="soi230031aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="soi230031aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="soi230031aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="R">Ran</given-names></name><degrees>PhD</degrees><xref rid="soi230031aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="soi230031aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bharadwaj</surname><given-names initials="KM">Kishore M.</given-names></name><degrees>MS</degrees><xref rid="soi230031aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="soi230031aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Johnson</surname><given-names initials="JJ">Jasmine J.</given-names></name><degrees>BS</degrees><xref rid="soi230031aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="soi230031aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gutierrez</surname><given-names initials="R">Rodrigo</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="soi230031aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="soi230031aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Das</surname><given-names initials="P">Proloy</given-names></name><degrees>PhD</degrees><xref rid="soi230031aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="soi230031aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Balanza</surname><given-names initials="G">Gustavo</given-names></name><degrees>MD</degrees><xref rid="soi230031aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="soi230031aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Deng</surname><given-names initials="H">Hao</given-names></name><degrees>MD</degrees><degrees>MPH</degrees><xref rid="soi230031aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="soi230031aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pandit</surname><given-names initials="A">Akriti</given-names></name><degrees>MPH</degrees><xref rid="soi230031aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="soi230031aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stone</surname><given-names initials="TAD">Tom A. D.</given-names></name><degrees>MS</degrees><xref rid="soi230031aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="soi230031aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Macdonald</surname><given-names initials="T">Teresa</given-names></name><degrees>RN</degrees><degrees>MSN</degrees><xref rid="soi230031aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="soi230031aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Horgan</surname><given-names initials="C">Caroline</given-names></name><degrees>RN</degrees><degrees>MSN</degrees><xref rid="soi230031aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tou</surname><given-names initials="SL">Si Long (Jenny)</given-names></name><degrees>BSc</degrees><xref rid="soi230031aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="soi230031aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Houle</surname><given-names initials="TT">Timothy T.</given-names></name><degrees>PhD</degrees><xref rid="soi230031aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="soi230031aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bittner</surname><given-names initials="EA">Edward A.</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="soi230031aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="soi230031aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Purdon</surname><given-names initials="PL">Patrick L.</given-names></name><degrees>PhD</degrees><xref rid="soi230031aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="soi230031aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="soi230031aff1"><label>1</label>Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston</aff><aff id="soi230031aff2"><label>2</label>Department of Anesthesia, Harvard Medical School, Boston, Massachusetts</aff><aff id="soi230031aff3"><label>3</label>Department of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts</aff><aff id="soi230031aff4"><label>4</label>Center for Perioperative Care, Department of Surgery, Massachusetts General Hospital, Boston</aff><author-notes><title>Article Information</title><p><bold>Accepted for Publication:</bold> March 19, 2023.</p><p content-type="published-online"><bold>Published Online:</bold> June 14, 2023. doi:<uri content-type="doi">10.1001/jamasurg.2023.2009</uri></p><p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://jamanetwork.com/pages/cc-by-license-permissions" ext-link-type="uri">CC-BY License</ext-link>. &#169; 2023 Santa Cruz Mercado LA et al. <italic toggle="yes">JAMA Surgery</italic>.</p><corresp id="soi230031cor1"><bold>Corresponding Author:</bold> Patrick L. Purdon, PhD, Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, 149 13th St, Charlestown, MA 02129 (<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="patrick.purdon@mgh.harvard.edu">patrick.purdon@mgh.harvard.edu</email>).</corresp><p content-type="author-contributions"><bold>Author Contributions:</bold> Drs Santa Cruz Mercado and Liu had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Drs Santa Cruz Mercado and Liu contributed equally as co&#8211;first authors. Drs Bittner and Purdon contributed equally as co&#8211;senior authors.</p><p><italic toggle="yes">Concept and design</italic>: Purdon, Santa Cruz Mercado, Bharadwaj, Johnson, Balanza Villegas, Deng, Tou, Houle, Bittner.</p><p><italic toggle="yes">Acquisition, analysis, or interpretation of data</italic>: All authors.</p><p><italic toggle="yes">Drafting of the manuscript</italic>: Purdon, Santa Cruz Mercado, Liu, Bharadwaj, Johnson, Gutierrez, Das, Balanza Villegas, Deng, Stone, MacDonald, Houle, Bittner.</p><p><italic toggle="yes">Critical revision of the manuscript for important intellectual content</italic>: Purdon, Santa Cruz Mercado, Liu, Bharadwaj, Deng, Pandit, Horgan, Tou, Houle, Bittner.</p><p><italic toggle="yes">Statistical analysis</italic>: Santa Cruz Mercado, Liu, Bharadwaj, Gutierrez, Das, Deng, Stone, Horgan, Tou, Bittner.</p><p><italic toggle="yes">Obtained funding</italic>: Purdon, Santa Cruz Mercado.</p><p><italic toggle="yes">Administrative, technical, or material support</italic>: Santa Cruz Mercado, Johnson, Gutierrez, Balanza Villegas, Pandit, Stone, MacDonald, Horgan, Houle, Bittner.</p><p><italic toggle="yes">Supervision</italic>: Purdon, Santa Cruz Mercado, Gutierrez, Houle, Bittner.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Santa Cruz Mercado, Mr Bharadwaj, Dr Balanza, and Dr Purdon are inventors on a pending patent related to nociception and analgesia monitoring. Dr Das reported grants from the National Institutes of Health during the conduct of the study. Dr Houle reported serving as statistical editor for the American Society of Anesthesiologists and the American Headache Society outside the submitted work. Dr Purdon reported grants from the National Institutes of Health and other from Massachusetts General Hospital where Dr Purdon holds the Nathaniel M. Sims Endowed Chair in Anesthesia Innovation and Bioengineering during the conduct of the study. In addition, Dr Purdon is a cofounder of PASCALL Systems, a startup company developing closed-loop physiological control for anesthesiology. Dr Purdon is an inventor on patents related to brain monitoring using the electroencephalogram, one of which is under nonexclusive license by Massachusetts General Hospital to Masimo Corporation. Dr Purdon receives institutionally distributed licensing royalties for this license. No other disclosures were reported.</p><p content-type="funding-statement"><bold>Funding/Support:</bold> This work was funded in part by <funding-source rid="sp1">National Institutes of Health</funding-source> grants R42DA053075 (PLP), R21DA048323 (PLP), F32GM148114 (RL).</p><p><bold>Role of the Funder/Sponsor:</bold> The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p><p><bold>Additional Contributions:</bold> We wish to recognize the superb contributions of Kishore M. Bharadwaj and Jasmine J. Johnson, who worked tirelessly to construct the exquisitely detailed data set analyzed here, which was purpose-built for this project. This result would not have been possible without their determined attention to detail and steadfast commitment to excellence.</p></author-notes><pub-date pub-type="ppub"><month>8</month><year>2023</year></pub-date><pub-date pub-type="epub" iso-8601-date="2023-06-14T10:00"><day>14</day><month>6</month><year>2023</year></pub-date><volume>158</volume><issue>8</issue><issue-id pub-id-type="pmc-issue-id">438231</issue-id><fpage>854</fpage><lpage>864</lpage><history><date date-type="received"><day>1</day><month>2</month><year>2023</year></date><date date-type="accepted"><day>19</day><month>3</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>14</day><month>06</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>15</day><month>06</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-08-11 00:25:09.277"><day>11</day><month>08</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Copyright 2023 Santa Cruz Mercado LA et al. <italic toggle="yes">JAMA Surgery</italic>.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the CC-BY License.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jamasurg-e232009.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf-version" xlink:href="jamasurg-e232009.pdf">jamasurg-e232009.pdf</self-uri><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="silverchair" xlink:href="https://jamanetwork.com/journals/archsurg/fullarticle/10.1001/jamasurg.2023.2009"/><abstract abstract-type="key-points"><title>Key Points</title><sec id="ab-soi230031-1"><title>Question</title><p>What is the association between intraoperative opioid administration and postoperative pain and opioid use?</p></sec><sec id="ab-soi230031-2"><title>Findings</title><p>In this cohort study of 61&#8201;249 individuals undergoing surgery, greater intraoperative fentanyl and hydromorphone administration was associated with decreased pain and opioid administration in postanesthesia care units. In particular, greater fentanyl administration was associated with decreased new chronic pain diagnoses at 3 months, decreased opioid prescriptions at 30, 90, and 180 days, and decreased new persistent opioid use, without significant increases in adverse effects.</p></sec><sec id="ab-soi230031-3"><title>Meaning</title><p>The results indicate that intraoperative opioid administration was associated with short- and long-term postoperative pain and opioid outcomes; reduced opioid administration during surgery may have the unintended outcome of increasing postoperative pain and opioid use.</p></sec></abstract><abstract abstract-type="teaser" specific-use="electronic"><p>This cohort study evaluates associations between intraoperative opioid use and postoperative pain and opioid use.</p></abstract><abstract><sec id="ab-soi230031-4"><title>Importance</title><p>Opioids administered to treat postsurgical pain are a major contributor to the opioid crisis, leading to chronic use in a considerable proportion of patients. Initiatives promoting opioid-free or opioid-sparing modalities of perioperative pain management have led to reduced opioid administration in the operating room, but this reduction could have unforeseen detrimental effects in terms of postoperative pain outcomes, as the relationship between intraoperative opioid usage and later opioid requirements is not well understood.</p></sec><sec id="ab-soi230031-5"><title>Objective</title><p>To characterize the association between intraoperative opioid usage and postoperative pain and opioid requirements.</p></sec><sec id="ab-soi230031-6"><title>Design, Setting, and Participants</title><p>This retrospective cohort study evaluated electronic health record data from a quaternary care academic medical center (Massachusetts General Hospital) for adult patients who underwent noncardiac surgery with general anesthesia from April 2016 to March 2020. Patients who underwent cesarean surgery, received regional anesthesia, received opioids other than fentanyl or hydromorphone, were admitted to the intensive care unit, or who died intraoperatively were excluded. Statistical models were fitted on the propensity weighted data set to characterize the effect of intraoperative opioid exposures on primary and secondary outcomes. Data were analyzed from December 2021 to October 2022.</p></sec><sec id="ab-soi230031-7"><title>Exposures</title><p>Intraoperative fentanyl and intraoperative hydromorphone average effect site concentration estimated using pharmacokinetic/pharmacodynamic models.</p></sec><sec id="ab-soi230031-8"><title>Main Outcomes and Measures</title><p>The primary study outcomes were the maximal pain score during the postanesthesia care unit (PACU) stay and the cumulative opioid dose, quantified in morphine milligram equivalents (MME), administered during the PACU stay. Medium- and long-term outcomes associated with pain and opioid dependence were also evaluated.</p></sec><sec id="ab-soi230031-9"><title>Results</title><p>The study cohort included a total of 61&#8201;249 individuals undergoing surgery (mean [SD] age, 55.44 [17.08] years; 32&#8201;778 [53.5%] female). Increased intraoperative fentanyl and intraoperative hydromorphone were both associated with reduced maximum pain scores in the PACU. Both exposures were also associated with a reduced probability and reduced total dosage of opioid administration in the PACU. In particular, increased fentanyl administration was associated with lower frequency of uncontrolled pain; a decrease in new chronic pain diagnoses reported at 3 months; fewer opioid prescriptions at 30, 90, and 180 days; and decreased new persistent opioid use, without significant increases in adverse effects.</p></sec><sec id="ab-soi230031-10"><title>Conclusions and Relevance</title><p>Contrary to prevailing trends, reduced opioid administration during surgery may have the unintended outcome of increasing postoperative pain and opioid consumption. Conversely, improvements in long-term outcomes might be achieved by optimizing opioid administration during surgery.</p></sec></abstract><funding-group><award-group><funding-source id="sp1">National Institutes of Health</funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="H1-1-SOI230031"><title>Introduction</title><p>The opioid crisis is a serious public health issue in the US.<sup><xref rid="soi230031r1" ref-type="bibr">1</xref>,<xref rid="soi230031r2" ref-type="bibr">2</xref></sup> About 1.7 million people experienced substance use disorders related to prescription opioid use in 2017.<sup><xref rid="soi230031r3" ref-type="bibr">3</xref></sup> In 2021, drug overdoses caused more than 100&#8201;000 deaths in the US; opioids were responsible for more than 75&#8201;000 of these deaths.<sup><xref rid="soi230031r4" ref-type="bibr">4</xref></sup> Postsurgical pain management is a major contributor to the crisis.<sup><xref rid="soi230031r5" ref-type="bibr">5</xref></sup> Of the 51 million patients who undergo surgery each year in the US, between 9% and 13% continue long-term use of opioids.<sup><xref rid="soi230031r6" ref-type="bibr">6</xref>,<xref rid="soi230031r7" ref-type="bibr">7</xref></sup> Moreover, a considerable proportion of surgical patients experience persistent postsurgical pain<sup><xref rid="soi230031r8" ref-type="bibr">8</xref></sup> and chronic pain,<sup><xref rid="soi230031r9" ref-type="bibr">9</xref></sup> and 8% to 12% of these individuals develop opioid use disorder.<sup><xref rid="soi230031r10" ref-type="bibr">10</xref></sup> As a result, initiatives began promoting opioid-free or opioid-sparing modalities of perioperative pain management.<sup><xref rid="soi230031r11" ref-type="bibr">11</xref>,<xref rid="soi230031r12" ref-type="bibr">12</xref>,<xref rid="soi230031r13" ref-type="bibr">13</xref></sup></p><p>In anesthesiology, the drive toward opioid reduction in surgical pain management has led to reduced intraoperative opioid usage during general anesthesia.<sup><xref rid="soi230031r14" ref-type="bibr">14</xref></sup> However, the effects of reduced intraoperative opioid usage on postoperative pain outcomes have not been well studied.<sup><xref rid="soi230031r15" ref-type="bibr">15</xref></sup> Some investigators have argued that this reduction may have unknown outcomes<sup><xref rid="soi230031r16" ref-type="bibr">16</xref></sup> and may prove detrimental for postoperative pain management.<sup><xref rid="soi230031r17" ref-type="bibr">17</xref></sup> Some studies indicate that intraoperative opioid administration can effect lasting reductions in postoperative pain, and thus reduce net opioid usage.<sup><xref rid="soi230031r18" ref-type="bibr">18</xref>,<xref rid="soi230031r19" ref-type="bibr">19</xref></sup> Conversely, inadequate perioperative pain relief has been associated with adverse patient outcomes. Uncontrolled pain can hinder postsurgical recovery, increasing mortality, duration of stay, and the risk of chronic pain, which in turn increases the likelihood of chronic opioid usage.<sup><xref rid="soi230031r8" ref-type="bibr">8</xref>,<xref rid="soi230031r20" ref-type="bibr">20</xref>,<xref rid="soi230031r21" ref-type="bibr">21</xref></sup></p><p>This study seeks to understand the association between intraoperative opioid administration and postoperative pain and opioid usage over the short and long term. We conducted a retrospective analysis of electronic health record data from a large cohort of surgical cases, using propensity weighting<sup><xref rid="soi230031r22" ref-type="bibr">22</xref></sup> to adjust for confounders on intraoperative opioid exposure.</p></sec><sec id="H1-2-SOI230031"><title>Methods</title><sec id="H2-1-SOI230031"><title>Design, Data Source, and Study Population</title><p>The study design and a waiver of informed consent were approved by the Massachusetts General Hospital institutional review board (2020P000301). We established an a priori statistical analysis plan that defined all variables, exposures, and outcomes, and outlined analysis procedures (eMethods in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p><p>The study included patients who underwent noncardiac surgery with general anesthesia at a quaternary academic medical center (Massachusetts General Hospital, Boston, Massachusetts) between April 1, 2016, and March 31, 2020. We used data from patient electronic health records and conducted a complete case analysis. Race and ethnicity were included as patient baseline variables, and their association with intraoperative exposure and clinician decision making were controlled for in our propensity weighting. These variables were also reported to provide an accurate account of the demographic characteristics of our study cohort. Categories were determined based on how these variables were recorded in the electronic health record (Epic) and on National Institutes of Health notice NOT-OD-15-089 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://grants.nih.gov/grants/guide/notice-files/not-od-15-089.html" ext-link-type="uri">https://grants.nih.gov/grants/guide/notice-files/not-od-15-089.html</ext-link>). We included patients 18 years and older who were admitted to the postanesthesia care unit (PACU) after surgery. We excluded patients who underwent cesarean surgery, received regional anesthesia as a complement to general anesthesia, received opioids other than fentanyl or hydromorphone during the exposure window, received postoperative patient-controlled analgesia, were admitted to the intensive care unit, or who died during the intraoperative period. Data were analyzed from December 2021 to October 2022.</p></sec><sec id="H2-2-SOI230031"><title>Exposures</title><p>The exposures we studied were the mean intraoperative effect site concentrations for fentanyl and hydromorphone. Effect site concentrations were computed using previously validated pharmacokinetic/pharmacodynamic models<sup><xref rid="soi230031r23" ref-type="bibr">23</xref>,<xref rid="soi230031r24" ref-type="bibr">24</xref></sup> parameterized by patient demographic characteristics and records of opioid administration (eMethods in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p></sec><sec id="H2-3-SOI230031"><title>Outcomes</title><p>The primary study outcomes were maximal pain score during the PACU stay and cumulative opioid dose administered in the PACU, quantified in morphine milligram equivalents (MME). Secondary outcomes included frequency of uncontrolled pain at 24 hours; new instances of chronic pain diagnosis between 3 months and 1 year; total opioid use at 24 hours and in the hospital; opioid prescriptions at 30, 90, and 180 postoperative days; frequency of new persistent opioid use at 90 and 180 days; maximal pain score in the first 24 hours and in the hospital; incidence of opioid-related complications in the PACU (ie, postoperative nausea and vomiting, sedation, and respiratory depression), length of stay in the PACU and in the hospital; 30-day readmission; and 30-day mortality (eMethods in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p></sec><sec id="H2-4-SOI230031"><title>Covariates</title><p>We included additional adjustment variables as covariates in each model to account for potential confounds occurring concurrently with or after the exposure (eTable 1 in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>). These variables increase modeling precision but are not interpreted, as they are not controlled for confounding.</p></sec><sec id="H2-5-SOI230031"><title>Statistical Analysis</title><p>We calculated a multivariate propensity score<sup><xref rid="soi230031r25" ref-type="bibr">25</xref></sup> for each patient using the specified confounding variables (eMethods in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>). This weighting controls for the effects of the confounding variables on the exposures. We calculated the correlation with exposures before and after reweighting using Pearson correlation for continuous and binary variables and the Kendall rank correlation<sup><xref rid="soi230031r26" ref-type="bibr">26</xref></sup> for ordinal variables. Outlier propensity weights above the 99.5th percentile were discarded.</p><p>We rescaled continuous variables to a mean of 0 and standard deviation of 1. We binarized categorical variables by one-hot encoding, which represents each category by an indicator variable. We used ordinal regression to model pain score outcomes (ie, PACU maximum pain score, 24-hour postoperative maximum pain score, and in-hospital maximum pain score). We used hurdle models consisting of a binomial logistic regression and a log-normal component for opioid usage outcomes (ie, PACU total MME, 24-hour postoperative total MME, and in-hospital total MME). We used Cox proportional hazard models to model time-to-event outcomes (ie, recovery from sedation, PACU length of stay, and hospital length of stay). We fitted logistic regression models for each binary outcome (ie, frequency of uncontrolled pain; 3-month and 12-month new chronic pain diagnoses; 30-day, 90-day, and 180-day opioid prescription; new persistent opioid use; postoperative nausea and vomiting in the PACU; respiratory depression; 30-day postoperative mortality; and 30-day postoperative readmission).</p><p>We conducted sensitivity analyses with control individuals for confounding of exposures by comorbidities and surgical complexity as represented by <italic toggle="yes">International Statistical Classification of Diseases and Related Health Problems, Tenth Revision</italic> (<italic toggle="yes">ICD-10</italic>) and <italic toggle="yes">Current Procedural Terminology</italic> (<italic toggle="yes">CPT</italic>) codes through propensity weighting on the impact of interaction terms in models of primary and secondary outcomes (eFigures 1-3 in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>) and in the subgroup of patients with body mass index (calculated as weight in kilograms divided by height in meters squared) greater than 30 (eFigures 4-5 in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p><p>We made counterfactual predictions of the mean expected difference in each outcome resulting from the additional administration of intraoperative fentanyl, 100 &#181;g, or intraoperative hydromorphone, 500 &#181;g, using fitted models, computed on the unweighted study population (eMethods in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>). For predictions of expected event times using Cox proportional hazard models,<sup><xref rid="soi230031r27" ref-type="bibr">27</xref></sup> we assumed a constant baseline hazard rate. We computed confidence intervals by bootstrap. Statistical analyses were performed using R version 4.2.2 (R Foundation).</p></sec></sec><sec id="H1-3-SOI230031"><title>Results</title><p>The study cohort included 61&#8201;249 individuals (mean [SD] age, 55.44 [17.08] years; 32&#8201;778 [53.5%] female) (<xref rid="soi230031f1" ref-type="fig">Figure 1</xref>). A total of 2084 individuals (3.4%) were Asian, 2972 (4.9%) were Black, 273 (0.4%) were Hispanic, 50&#8201;093 (81.8%) were White, and 5827 (9.5%) were of another race or ethnicity (including American Indian or Alaska Native, Native Hawaiian or Other Pacific Islander, or recorded values that did not fall into any of the National Institutes of Health Office of Management and Budget&#8211;defined categories, such as unavailable or multiple; these categories were consolidated as their numbers were too few for accurate statistical inference or had values that were not informative) (<xref rid="soi230031t1" ref-type="table">Table 1</xref>). Orthopedic, general, urological, gynecological, and plastic were the most frequent operations, and together made up 72.3% of all included procedures. A total of 1957 unique <italic toggle="yes">CPT</italic> codes were associated with these procedures; the 25 most frequent made up 37.2% of operations (eTable 2 in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>). Propensity weighting reduced correlations between exposures and confounding variables (eMethods in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p><fig position="float" id="soi230031f1" fig-type="figure" orientation="portrait"><label>Figure 1. </label><caption><title>Flow Diagram of Study Population</title><p>PACU indicates postanesthesia care unit; PCA, patient-controlled analgesia; PK/PD, pharmacokinetic/pharmacodynamic.</p><p><sup>a</sup>Some individuals met multiple exclusion criteria.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jamasurg-e232009-g001.jpg"/></fig><table-wrap position="float" id="soi230031t1" orientation="portrait"><label>Table 1. </label><caption><title>Baseline Statistics and Clinical Characteristics With Propensity-Weighted Correlations of Study Population</title></caption><table frame="hsides" rules="groups"><col width="28.11%" span="1"/><col width="23.96%" span="1"/><col width="23.96%" span="1"/><col width="23.97%" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Statistic</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">No. (%)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Correlation with fentanyl (unweighted/weighted)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Correlation with hydromorphone (unweighted/weighted)</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total No. of patients</td><td valign="top" align="left" rowspan="1" colspan="1">61&#8201;249 (100)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Demographic characteristics</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Age, mean (SD) y</td><td valign="top" align="left" rowspan="1" colspan="1">55.44 (17.08)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.06/&#8722;0.02</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.12/&#8722;0.08</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Sex</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Male</td><td valign="top" align="left" rowspan="1" colspan="1">28&#8201;471 (46.48)</td><td rowspan="2" valign="middle" align="center" colspan="1">&#8722;0.09/&#8722;0.04</td><td rowspan="2" valign="middle" align="center" colspan="1">&#8722;0.02/&#8722;0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Female</td><td valign="top" align="left" rowspan="1" colspan="1">32&#8201;778 (53.52)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Race and ethnicity </td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Asian</td><td valign="top" align="left" rowspan="1" colspan="1">2084 (3.4)</td><td valign="top" align="left" rowspan="1" colspan="1">0.04/&#8722;0.01</td><td valign="top" align="left" rowspan="1" colspan="1">0.00/0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Black</td><td valign="top" align="left" rowspan="1" colspan="1">2972 (4.9)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.01</td><td valign="top" align="left" rowspan="1" colspan="1">0.00/0.05</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hispanic</td><td valign="top" align="left" rowspan="1" colspan="1">273 (0.4)</td><td valign="top" align="left" rowspan="1" colspan="1">0.00/&#8722;0.01</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> White</td><td valign="top" align="left" rowspan="1" colspan="1">50&#8201;093 (81.8)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.02/0.01</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.00/&#8722;0.05</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other<xref rid="soi230031t1n2" ref-type="table-fn"><sup>b</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">5827 (9.5)</td><td valign="top" align="left" rowspan="1" colspan="1">0.01/0.01</td><td valign="top" align="left" rowspan="1" colspan="1">0.01/0.03</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Clinical characteristics</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> ASA physical status classification</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> I</td><td valign="top" align="left" rowspan="1" colspan="1">6951 (11.35)</td><td rowspan="4" valign="middle" align="center" colspan="1">&#8722;0.06/&#8722;0.00</td><td rowspan="4" valign="middle" align="center" colspan="1">&#8722;0.05/&#8722;0.00</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> II</td><td valign="top" align="left" rowspan="1" colspan="1">36&#8201;013 (58.80)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> III</td><td valign="top" align="left" rowspan="1" colspan="1">17&#8201;405 (28.42)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> IV</td><td valign="top" align="left" rowspan="1" colspan="1">880 (1.44)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> BMI<xref rid="soi230031t1n3" ref-type="table-fn"><sup>c</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">27.26 (23.78 to 31.63)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.25/&#8722;0.05</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.09/&#8722;0.10</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Ambulatory surgery</td><td valign="top" align="left" rowspan="1" colspan="1">29&#8201;165 (47.62)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Inpatient surgery</td><td valign="top" align="left" rowspan="1" colspan="1">32&#8201;084 (52.38)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.03/&#8722;0.03</td><td valign="top" align="left" rowspan="1" colspan="1">0.17/0.13</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Surgical service</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Orthopedic surgery</td><td valign="top" align="left" rowspan="1" colspan="1">14&#8201;033 (22.91)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.05/&#8722;0.04</td><td valign="top" align="left" rowspan="1" colspan="1">0.12/0.11</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> General surgery</td><td valign="top" align="left" rowspan="1" colspan="1">10&#8201;539 (17.21)</td><td valign="top" align="left" rowspan="1" colspan="1">0.03/0.03</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.06/&#8722;0.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Urology</td><td valign="top" align="left" rowspan="1" colspan="1">8596 (14.03)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.06/&#8722;0.01</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.09/&#8722;0.08</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Gynecology</td><td valign="top" align="left" rowspan="1" colspan="1">6177 (10.09)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.00/0.05</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.02/&#8722;0.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Plastic surgery</td><td valign="top" align="left" rowspan="1" colspan="1">4920 (8.03)</td><td valign="top" align="left" rowspan="1" colspan="1">0.01/&#8722;0.00</td><td valign="top" align="left" rowspan="1" colspan="1">0.05/0.04</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other</td><td valign="top" align="left" rowspan="1" colspan="1">16&#8201;984 (27.73)</td><td valign="top" align="left" rowspan="1" colspan="1">0.06/&#8722;0.01</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.03</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Procedural severity score</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Morbidity</td><td valign="top" align="left" rowspan="1" colspan="1">33.45 (19.02)</td><td valign="top" align="left" rowspan="1" colspan="1">0.03/&#8722;0.02</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.02/0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mortality</td><td valign="top" align="left" rowspan="1" colspan="1">53.40 (34.68)</td><td valign="top" align="left" rowspan="1" colspan="1">0.05/&#8722;0.00</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.04/&#8722;0.00</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">30-d Mortality</td><td valign="top" align="left" rowspan="1" colspan="1">256 (0.42)</td><td valign="top" align="left" rowspan="1" colspan="1">0.00/0.01</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">30-d Readmission</td><td valign="top" align="left" rowspan="1" colspan="1">4407 (7.20)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.03</td><td valign="top" align="left" rowspan="1" colspan="1">0.05/0.05</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Surgical duration, median, IQR, h</td><td valign="top" align="left" rowspan="1" colspan="1">1.15 (0.63 to 1.98)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.03</td><td valign="top" align="left" rowspan="1" colspan="1">0.02/0.05</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PACU length of stay, median, IQR, h</td><td valign="top" align="left" rowspan="1" colspan="1">1.52 (1.05 to 2.17)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.03</td><td valign="top" align="left" rowspan="1" colspan="1">0.02/0.05</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Inpatient hospital length of stay, median, IQR, h</td><td valign="top" align="left" rowspan="1" colspan="1">56.14 (30.95 to 130.25)</td><td valign="top" align="left" rowspan="1" colspan="1">0.00/&#8722;0.05</td><td valign="top" align="left" rowspan="1" colspan="1">0.16/0.16</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Elixhauser comorbidity index, median, IQR </td><td valign="top" align="left" rowspan="1" colspan="1">1.00 (0.0 to 7.0)</td><td valign="top" align="left" rowspan="1" colspan="1">0.00/&#8722;0.08</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.04/&#8722;0.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Opioid naivety</td><td valign="top" align="left" rowspan="1" colspan="1">49&#8201;428 (80.70)</td><td valign="top" align="left" rowspan="1" colspan="1">0.02/&#8722;0.01</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.04/&#8722;0.02</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Intraoperative characteristics</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mean blood pressure, mm Hg</td><td valign="top" align="left" rowspan="1" colspan="1">81.53 (9.44)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.04/0.07</td><td valign="top" align="left" rowspan="1" colspan="1">0.01/&#8722;0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Heart rate, bpm</td><td valign="top" align="left" rowspan="1" colspan="1">71.50 (11.65)</td><td valign="top" align="left" rowspan="1" colspan="1">0.05/0.04</td><td valign="top" align="left" rowspan="1" colspan="1">0.11/0.12</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hypertensive duration, median, IQR, min</td><td valign="top" align="left" rowspan="1" colspan="1">5.00 (0.00 to 17.00)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.03/&#8722;0.00</td><td valign="top" align="left" rowspan="1" colspan="1">0.06/0.09</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hypotensive duration, median, IQR, min</td><td valign="top" align="left" rowspan="1" colspan="1">44.00 (18.00 to 83.00)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.14/&#8722;0.13</td><td valign="top" align="left" rowspan="1" colspan="1">0.08/0.06</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Vasopressors, median, IQR, &#181;g/kg/min norepinephrine equivalents</td><td valign="top" align="left" rowspan="1" colspan="1">0.00 (0.00 to 0.01)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.02</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Blood loss, median, IQR, mL</td><td valign="top" align="left" rowspan="1" colspan="1">2.00 (0.00 to 50.00)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.05/&#8722;0.04</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Blood transfusion</td><td valign="top" align="left" rowspan="1" colspan="1">1852 (3.02)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.04</td><td valign="top" align="left" rowspan="1" colspan="1">0.07/0.07</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Anesthesia</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> N2O</td><td valign="top" align="left" rowspan="1" colspan="1">43&#8201;245 (70.61)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.04</td><td valign="top" align="left" rowspan="1" colspan="1">0.01/0.05</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Desflurane</td><td valign="top" align="left" rowspan="1" colspan="1">733 (1.20)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.22/&#8722;0.23</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.07/&#8722;0.15</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Isoflurane</td><td valign="top" align="left" rowspan="1" colspan="1">4628 (7.56)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.02/&#8722;0.03</td><td valign="top" align="left" rowspan="1" colspan="1">0.04/0.08</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Propofol</td><td valign="top" align="left" rowspan="1" colspan="1">59&#8201;188 (96.64)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.01</td><td valign="top" align="left" rowspan="1" colspan="1">0.00/0.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Sevoflurane</td><td valign="top" align="left" rowspan="1" colspan="1">54&#8201;025 (88.21)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.06/&#8722;0.06</td><td valign="top" align="left" rowspan="1" colspan="1">0.10/0.09</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Neuromuscular blocks</td><td valign="top" align="left" rowspan="1" colspan="1">20&#8201;086 (32.79)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.11/&#8722;0.05</td><td valign="top" align="left" rowspan="1" colspan="1">0.08/0.05</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Antiemetic prophylaxis</td><td valign="top" align="left" rowspan="1" colspan="1">12&#8201;349 (20.16)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.02/&#8722;0.05</td><td valign="top" align="left" rowspan="1" colspan="1">0.15/0.13</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Nonopioid analgesia</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Ketorolac</td><td valign="top" align="left" rowspan="1" colspan="1">15&#8201;685 (25.61)</td><td valign="top" align="left" rowspan="1" colspan="1">0.03/0.03</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.03/&#8722;0.05</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Acetaminophen</td><td valign="top" align="left" rowspan="1" colspan="1">2275 (3.71)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.03/&#8722;0.03</td><td valign="top" align="left" rowspan="1" colspan="1">0.00/&#8722;0.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Ketamine</td><td valign="top" align="left" rowspan="1" colspan="1">3367 (5.50)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.06/&#8722;0.06</td><td valign="top" align="left" rowspan="1" colspan="1">0.08/0.05</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Dexmedetomidine</td><td valign="top" align="left" rowspan="1" colspan="1">1395 (2.28)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.05/&#8722;0.04</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.04</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Esmolol</td><td valign="top" align="left" rowspan="1" colspan="1">7071 (11.54)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.01</td><td valign="top" align="left" rowspan="1" colspan="1">0.00/0.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Lidocaine</td><td valign="top" align="left" rowspan="1" colspan="1">49&#8201;888 (81.45)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.03/&#8722;0.03</td><td valign="top" align="left" rowspan="1" colspan="1">0.01/&#8722;0.01</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Postoperative complications</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Respiratory depression</td><td valign="top" align="left" rowspan="1" colspan="1">941 (1.54)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.00/0.00</td><td valign="top" align="left" rowspan="1" colspan="1">0.01/0.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> PONV in PACU</td><td valign="top" align="left" rowspan="1" colspan="1">1642 (2.68)</td><td valign="top" align="left" rowspan="1" colspan="1">0.00/0.01</td><td valign="top" align="left" rowspan="1" colspan="1">0.01/0.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Difficult intubation</td><td valign="top" align="left" rowspan="1" colspan="1">257 (0.42)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.01</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01/&#8722;0.02</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; NA, not applicable; PACU, postanesthesia care unit; PONV, postoperative nausea and vomiting.</p><fn id="soi230031t1n1"><label>
<sup>a</sup>
</label><p>Race and ethnicity were included as patient baseline variables, and their association with intraoperative exposure and clinician decision-making were controlled for in our propensity weighting. These variables were also reported to provide an accurate account of the demographic characteristics of our study cohort. Categories were determined based on how these variables were recorded in the electronic health record (Epic) and on National Institutes of Health notice NOT-OD-15-089 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://grants.nih.gov/grants/guide/notice-files/not-od-15-089.html" ext-link-type="uri">https://grants.nih.gov/grants/guide/notice-files/not-od-15-089.html</ext-link>).</p></fn><fn id="soi230031t1n2"><label>
<sup>b</sup>
</label><p>Including American Indian or Alaska Native, Native Hawaiian or Other Pacific Islander, or recorded values that did not fall into any of the National Institutes of Health Office of Management and Budget&#8211;defined categories, such as unavailable or multiple; these categories were consolidated as their numbers were too few for accurate statistical inference or had values that were not informative.</p></fn><fn id="soi230031t1n3"><label>
<sup>c</sup>
</label><p>Calculated as weight in kilograms divided by height in meters squared.</p></fn></table-wrap-foot></table-wrap><p>Both intraoperative exposure variables are bimodally distributed (<xref rid="soi230031f2" ref-type="fig">Figure 2</xref>A and B),<sup><xref rid="soi230031r28" ref-type="bibr">28</xref></sup> with 1 peak at 0. The median (IQR) exposures were 0.50 (0.35-0.68) ng/mL of fentanyl and 0.50 (0.00-0.96) ng/mL of hydromorphone, and the 95th percentile exposures were 1.07 ng/mL of fentanyl and 2.04 ng/mL of hydromorphone. The 2 exposure variables were approximately independent, with a Pearson correlation of &#8722;0.03. During our defined exposure window, 4501 patients (7.3%) received no fentanyl, and 22&#8201;299 patients (36.4%) received no hydromorphone. Fentanyl administration tended to occur toward the beginning of the exposure window, while hydromorphone administration tended to be homogenously distributed along the exposure window (eFigure 6 in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>). PACU maximum pain score (<xref rid="soi230031f2" ref-type="fig">Figure 2</xref>C) and PACU total MME (<xref rid="soi230031f2" ref-type="fig">Figure 2</xref>D) also followed a bimodal distribution, with a maximum pain score of 0 in the PACU and no opioids given in the PACU as modal values. Maximum pain score in the 24 postoperative hours and in the hospital were distributed similarly to PACU maximum pain (eFigure 7 in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>). The median (IQR) number of pain assessments per patient was 3 (4-6) in the PACU, 14 (11-18) in the 24 hours following surgery, and 23 (14-43) in the hospital (eFigure 8 in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>). We also examined mean opioid administration by year at Massachusetts General Hospital, which showed a decrease over time (eFigure 9 in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>), and the total dosage of fentanyl and hydromorphone administered between patient arrival in the operating room and the end of the exposure window (eFigure 10 in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p><fig position="float" id="soi230031f2" fig-type="figure" orientation="portrait"><label>Figure 2. </label><caption><title>Population Distribution of Exposures and Primary Outcomes</title><p>A, Vertical dashed lines represent the EC50 and EC95 for intraoperative fentanyl based on Vuyk et al.<sup><xref rid="soi230031r28" ref-type="bibr">28</xref></sup> MME indicates morphine milligram equivalent; PACU, postanesthesia care unit.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jamasurg-e232009-g002.jpg"/></fig><sec id="H2-6-SOI230031"><title>Modeling of Primary and Secondary Outcomes</title><p>We fit statistical models on the propensity-weighted data set to describe the effect of intraoperative opioid exposures on primary and secondary outcomes (<xref rid="soi230031f3" ref-type="fig">Figure 3</xref>). Intraoperative fentanyl and intraoperative hydromorphone were both associated with lower maximum pain scores in the PACU. Both exposures were also associated with a lower probability of opioid administration in the PACU, indicated by a negative coefficient in the binomial component of the PACU total MME hurdle model, and lower total opioid dosage in the PACU, indicated by a negative coefficient in the log-normal component.</p><fig position="float" id="soi230031f3" fig-type="figure" orientation="portrait"><label>Figure 3. </label><caption><title>Adjusted Odds Ratios (aOR) for Primary and Secondary Outcomes</title><p>The forest plot represents adjusted odds ratios with confidence intervals for each outcome for intraoperative fentanyl and hydromorphone exposure. We calculated odds ratios by exponentiating model coefficients. For hierarchical models, both components are presented (binomial and log-normal). For Cox proportional hazards models, adjusted odds ratios for expected time to event are presented. MME indicates morphine milligram equivalent; PACU, postanesthesia care unit; PONV, postoperative nausea and vomiting.</p><p><sup>a</sup>Secondary outcomes that were evaluated only in the subset of inpatients.</p><p><sup>b</sup>We computed hazard ratios by exponentiating coefficients of Cox proportional hazards models, which are ratios of rates of event occurrence to population baseline rates. Greater hazard rates predict shorter event occurrence times; for example, for a 1-SD increase in intraoperative fentanyl exposure, our model predicts a hazard ratio with a 95% CI from 1.04 to 1.10, indicating an increased rate of hospital discharge, and a shorter length of stay.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jamasurg-e232009-g003.jpg"/></fig><p>Hydromorphone and fentanyl had different patterns of model-predicted associations with some medium- to long-term outcomes. Intraoperative fentanyl was associated with reduced total opioid administration over the postoperative 24-hour period and with reduced total in-hospital opioid administration. Intraoperative hydromorphone administration was also associated with reduced total opioid administration over the postoperative 24-hour period and with a lower probability of opioid administration in the hospital, but was associated with greater opioid administration in the hospital conditioned on nonzero opioid administration. Intraoperative fentanyl exposure was associated with a shorter hospital length of stay, whereas intraoperative hydromorphone was associated with a longer hospital length of stay. Intraoperative fentanyl was associated with reduced frequency of uncontrolled pain as well as reduced opioid prescriptions at 30, 90, and 180 days, whereas intraoperative hydromorphone was associated with a slight increase in 30-, 90-, and 180-day opioid prescriptions.</p></sec><sec id="H2-7-SOI230031"><title>Counterfactual Predictions</title><p>We computed the expected association of the addition of fentanyl, 100 &#181;g, or hydromorphone, 500 &#181;g, with the observed intraoperative exposure of each patient in our study population (<xref rid="soi230031t2" ref-type="table">Table 2</xref>). These analyses indicated that a 100-&#181;g increase in intraoperative fentanyl would correspond to a 0.49-point mean reduction in maximum pain score in the PACU and a 500-&#181;g increase in intraoperative hydromorphone would correspond to a 0.08-point mean reduction in maximum pain score in the PACU.</p><table-wrap position="float" id="soi230031t2" orientation="portrait"><label>Table 2. </label><caption><title>Counterfactual Predictions</title></caption><table frame="hsides" rules="groups"><col width="33.86%" span="1"/><col width="32.14%" span="1"/><col width="34%" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Change in outcome</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Expected change (95% CI)</th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">With additional 100 &#181;g of fentanyl</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">With additional 500 &#181;g of hydromorphone</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Primary PACU maximum pain score</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.49 (&#8722;0.53 to &#8722;0.44)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.08 (&#8722;0.11 to &#8722;0.06)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">24-h Postoperative maximum pain</td><td valign="top" align="left" rowspan="1" colspan="1">0.09 (0.03 to 0.15)</td><td valign="top" align="left" rowspan="1" colspan="1">0.07 (0.04 to 0.10)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">In-hospital maximum pain</td><td valign="top" align="left" rowspan="1" colspan="1">0.01 (&#8722;0.05 to 0.06)</td><td valign="top" align="left" rowspan="1" colspan="1">0.24 (0.21 to 0.27)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Primary PACU total MME<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.36 (&#8722;0.43 to &#8722;0.29); &#8722;12.7 (&#8722;15.3 to &#8722;10.2)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.41 (&#8722;0.46 to &#8722;0.35); &#8722;14.4 (&#8722;16.3 to &#8722;12.5)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">24-h Postoperative total MME<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;4.9 (&#8722;5.2 to &#8722;4.6); &#8722;45.6 (&#8722;48.2 to &#8722;42.8)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;1.5 (&#8722;1.6 to &#8722;1.3); &#8722;13.4 (&#8722;14.8 to &#8722;12.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">In-hospital total MME<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;16.6 (&#8722;18.6 to &#8722;14.9); &#8722;38.6 (&#8722;42.9 to &#8722;34.4)</td><td valign="top" align="left" rowspan="1" colspan="1">3.5 (2.6 to 4.6); 8.2 (6.0 to 10.7)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Time to recovery from sedation, min<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">1.80 (1.47 to 3.72); 5.1 (4.2 to 10.6)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.57 (&#8722;1.70 to 0.11); &#8722;1.6 (&#8722;4.9 to 0.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PACU length of stay, min<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">0.48 (&#8722;0.96 to 2.34); 0.7 (&#8722;1.4 to 3.4)</td><td valign="top" align="left" rowspan="1" colspan="1">1.54 (1.30 to 3.17); 2.2 (1.9 to 4.6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hospital length of stay, min<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;444.8 (&#8722;569.9 to &#8722;317.5); &#8722;11.1 (&#8722;14.3 to &#8722;8.0)</td><td valign="top" align="left" rowspan="1" colspan="1">563.9 (493.7 to 632.0); 14.1 (12.4 to 15.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Frequency of uncontrolled pain (No. per 1000)<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;4.71 (&#8722;6.46 to &#8722;4.16); &#8722;56.3 (&#8722;77.3 to &#8722;49.8)</td><td valign="top" align="left" rowspan="1" colspan="1">0.59 (&#8722;0.33 to 1.76); 7.1 (&#8722;4.0 to 21.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">3-mo New chronic pain diagnosis (No. per 1000)<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;1.34 (&#8722;2.25 to &#8722;0.46); &#8722;30.3 (&#8722;50.9 to &#8722;10.3)</td><td valign="top" align="left" rowspan="1" colspan="1">0.80 (0.33 to 1.50); 18.0 (7.4 to 33.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">12-mo New chronic pain diagnosis (No. per 1000)<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;2.28 (&#8722;4.31 to &#8722;0.06); &#8722;11.9 (&#8722;22.6 to &#8722;0.3)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;1.79 (&#8722;2.94 to &#8722;0.62); &#8722;9.3 (&#8722;15.4 to &#8722;3.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">30-d Opioid prescription (No. per 1000)<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;31.16 (&#8722;37.54 to &#8722;24.69); &#8722;12.2 (&#8722;14.7 to &#8722;9.7)</td><td valign="top" align="left" rowspan="1" colspan="1">10.29 (6.39 to 14.11); 4.0 (2.5 to 5.5)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">90-d Opioid prescription (No. per 1000)<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;36.16 (&#8722;42.74 to &#8722;29.32); &#8722;13.3 (&#8722;15.7 to &#8722;10.8)</td><td valign="top" align="left" rowspan="1" colspan="1">14.60 (10.68 to 18.58); 5.4 (3.9 to 6.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">180-d Opioid prescription (No. per 1000)<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;35.04 (&#8722;41.72 to &#8722;28.70); &#8722;12.3 (&#8722;14.7 to &#8722;10.1)</td><td valign="top" align="left" rowspan="1" colspan="1">13.08 (9.16 to 17.05); 4.6 (3.2 to 6.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">New persistent opioid use (No. per 1000)<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;21.29 (&#8722;26.98 to &#8722;15.74); &#8722;12.4 (&#8722;15.7 to &#8722;9.2)</td><td valign="top" align="left" rowspan="1" colspan="1">12.74 (9.45 to 16.07); 7.4 (5.5 to 9.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PONV in PACU (No. per 1000)<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;1.41 (&#8722;4.56 to 2.06); &#8722;4.8 (&#8722;15.6 to 7.0)</td><td valign="top" align="left" rowspan="1" colspan="1">7.78 (4.73 to 11.07); 26.6 (16.2 to 37.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Respiratory depression in PACU (No. per 1000)<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">0.13 (&#8722;2.08 to 2.86); 0.9 (&#8722;14.5 to 19.9)</td><td valign="top" align="left" rowspan="1" colspan="1">4.97 (2.44 to 8.16); 34.7 (17.0 to 56.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">30-d Postoperative mortality (No. per 1000)<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">0.93 (&#8722;0.029 to 2.34); 29.4 (&#8722;0.9 to 73.9)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.89 (&#8722;1.47 to &#8722;0.45); &#8722;28.2 (&#8722;46.6 to &#8722;14.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">30-d Postoperative readmission (No. per 1000)<xref rid="soi230031t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;10.48 (&#8722;13.94 to &#8722;6.77); &#8722;16.2 (&#8722;21.5 to &#8722;10.4)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.75 (&#8722;2.54 to 1.20); &#8722;1.2 (&#8722;3.9 to 1.8)</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: MME, morphine milligram equivalents; PACU, postanesthesia care unit; PONV, postoperative nausea and vomiting.</p><fn id="soi230031t2n1"><label>
<sup>a</sup>
</label><p>Also reported as percentages with 95% CIs.</p></fn></table-wrap-foot></table-wrap><p>For postoperative opioid administration, we found that a 100-&#181;g increase in intraoperative fentanyl would correspond to mean reductions of 0.36 MME postoperative opioid administration in the PACU (&#8722;12.7%), 4.9 MME at 24 hours (&#8722;45.6%), and 16.6 MME in the hospital (&#8722;38.6%). Meanwhile, a 500-&#181;g increase in intraoperative hydromorphone would correspond to mean reductions of 0.41 MME of opioid administration in the PACU (&#8722;14.4%) and 1.5 MME at 24 hours (&#8722;17.7%) and an increase of 3.5 MME in the hospital (+8.2%). We also found that a 100-&#181;g increase in intraoperative fentanyl would correspond to a 5.1-hour reduction in hospital length of stay (&#8722;7.7%), whereas a 500-&#181;g increase in intraoperative hydromorphone would correspond to a 6.5-hour increase in hospital length of stay (+9.8%).</p><p>For opioid prescriptions, we found that a 100-&#181;g increase in intraoperative fentanyl would correspond to decreases of 31.2 instances per 1000 after 30 days (&#8722;12.2%), 36.2 instances per 1000 after 90 days (&#8722;13.3%), and 35.0 instances per 1000 after 180 days (&#8722;12.3%), alongside a decrease of 21.3 instances per 1000 of new persistent opioid use (&#8722;12.4%). A 500-&#181;g increase in intraoperative hydromorphone would correspond to increases of 10.3 opioid prescriptions per 1000 after 30 days (+4.0%), 14.6 opioid prescriptions per 1000 after 90 days (+5.4%), and 13.1 opioid prescriptions per 1000 after 180 days (+4.6%), alongside an increase of 12.7 instances of new persistent opioid use per 1000 (+7.4%).</p></sec></sec><sec id="H1-4-SOI230031"><title>Discussion</title><sec id="H2-8-SOI230031"><title>Clinical Significance</title><p>In this cohort study, we sought to understand the associations between intraoperative opioid administration and both short- and long-term outcomes with respect to postoperative pain and opioid administration through statistical modeling of a large study cohort representative of a broad general population of surgical patients. Our primary analyses indicate that increased intraoperative administration of both fentanyl and hydromorphone was associated with reduced postoperative pain in the PACU and lower quantities of opioids administered in the PACU. Our results also suggest that intraoperative mitigation of surgical nociception may have lasting effects on long-term pain and subsequent opioid use. Therefore, it may be necessary to reevaluate opioid-sparing anesthetic regimens since reductions in intraoperative opioid usage may have the unintended effect of worsening long-term pain and increasing overall opioid use.</p><p>Intraoperative opioid administration may also impact health care costs and efficiency. We found that higher fentanyl administration was associated with reduced length of stay and 30-day readmissions without an increase in adverse effects. Other the other hand, increased hydromorphone administration was associated with increased length of stay, respiratory depression, and postoperative nausea and vomiting.</p><p>We were surprised by the extent to which intraoperative administration of opioids was associated with medium- and long-term outcomes. This may relate to the fact that if inadequate amounts of opioids are administered in the operating room, patients may emerge from general anesthesia in pain, a phenomenon that has a known association with persistent postsurgical pain.<sup><xref rid="soi230031r8" ref-type="bibr">8</xref>,<xref rid="soi230031r9" ref-type="bibr">9</xref>,<xref rid="soi230031r29" ref-type="bibr">29</xref>,<xref rid="soi230031r30" ref-type="bibr">30</xref></sup></p><p>Fentanyl and hydromorphone appear to have had different associations with some medium- and long-term outcomes. This difference may involve the timing of drug administration. In our cohort, fentanyl tended to be administered earlier than hydromorphone. Furthermore, fentanyl has a much shorter duration of effect than hydromorphone<sup><xref rid="soi230031r31" ref-type="bibr">31</xref>,<xref rid="soi230031r32" ref-type="bibr">32</xref>,<xref rid="soi230031r33" ref-type="bibr">33</xref></sup> so its activity is largely confined to the intraoperative period, whereas hydromorphone continues acting into the postoperative period. This may indicate that the moment-to-moment control of nociception during surgery could influence medium- and long-term outcomes more strongly than long-acting opioids administered near the end of a procedure with the intent of controlling postoperative pain. Ultimately, randomized clinical trials assessing the relationship between the timing of opioid administration and pain-related outcomes are necessary, as our models quantify exposure-outcome associations but cannot conclusively identify the mechanisms responsible.</p></sec><sec id="H2-9-SOI230031"><title>Counterfactual Predictions</title><p>Our counterfactual predictions contextualize the magnitude of effects stemming from typical clinically relevant incremental doses of fentanyl and hydromorphone.<sup><xref rid="soi230031r34" ref-type="bibr">34</xref>,<xref rid="soi230031r35" ref-type="bibr">35</xref></sup> The predicted percentage reduction in hospital-administered MME, opioid prescriptions through 180 days, and new persistent opioid use after an incremental 100-&#181;g dose of fentanyl appear comparable to the outcomes of major interventions in opioid prescribing practices.<sup><xref rid="soi230031r36" ref-type="bibr">36</xref>,<xref rid="soi230031r37" ref-type="bibr">37</xref>,<xref rid="soi230031r38" ref-type="bibr">38</xref>,<xref rid="soi230031r39" ref-type="bibr">39</xref></sup> This same dose of fentanyl also predicted a significant reduction in length of stay. While opioid prescribing practices shift toward limitation, our counterfactual predictions would seem to reflect a reduction in the intrinsic need for opioids after surgery attained by improved control of intraoperative nociception. Our counterfactual analysis also predicted that incremental amounts of hydromorphone might increase opioid prescriptions through 180 days and new persistent opioid use, which may reflect differences in drug mechanisms and timing.</p></sec><sec id="H2-10-SOI230031"><title>Pharmacokinetic/Pharmacodynamic Modeling</title><p>The mean effect site concentration of fentanyl and hydromorphone during the exposure window was computed using pharmacokinetic/pharmacodynamic modeling. While pharmacokinetic/pharmacodynamic models cannot represent a drug&#8217;s behavior at the individual level, these models provide a sound theoretical basis for estimating opioid concentrations on average for a population of patients, accounting for variables such as weight, height, and age.<sup><xref rid="soi230031r40" ref-type="bibr">40</xref></sup> Effect site concentrations place current patterns of opioid administration in the context of the known pharmacodynamics of these drugs: in this cohort, fentanyl is generally administered well below its EC50.<sup><xref rid="soi230031r28" ref-type="bibr">28</xref></sup> Furthermore, we found that fentanyl administration in this cohort decreased between 2016 and 2020 (eFigure 9 in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>). This trend toward decreasing intraoperative opioid administration has been well documented at many other institutions in the US.<sup><xref rid="soi230031r14" ref-type="bibr">14</xref></sup></p></sec><sec id="H2-11-SOI230031"><title>Limitations</title><p>This study has limitations. Because the study population is derived from patients at a single medical center, our findings reflect its patterns of practice. While our models predict overall improvements in outcome with increased intraoperative opioid administration, increased intraoperative opioid administration may prove detrimental in a clinical setting where typical care involves a higher level of intraoperative opioid administration. The generalizability of our study may also be limited by the relatively low proportion of patients from various racial and ethnicity groups.</p><p>While propensity weighting produced low correlations between exposures and confounders, some residual confounding inevitably remains. Our finding that greater hydromorphone exposure was associated with on some detrimental long-term outcomes may be influenced by residual confounding; that is, patients undergoing more painful operations may have received more hydromorphone even after rebalancing. Our sensitivity analysis (eFigure 1 in <xref rid="note-SOI230031-1-s" ref-type="supplementary-material">Supplement 1</xref>) showed that altering the set of controlled confounding variables to account for comorbidities and surgical complexity influenced the magnitude of the modeled effects of the intraoperative exposures but did not change their direction or subjective interpretation.</p></sec></sec><sec id="H1-5-SOI230031"><title>Conclusions</title><p>The main implication of this study is that in the drive toward overall reduction of opioid usage in surgical pain management in the US, the role of intraoperative nociception in determining postoperative pain may have been overlooked to the detriment of patient outcomes. Adequate intraoperative nociception management, particularly with fentanyl, may result in improvements in postoperative pain management with a lower total quantity of opioid administration and a subsequent lower rate of new persistent opioid use, fewer opioid prescription refills, and fewer cases of chronic pain as far out as 12 months after surgery. These results raise important questions that require randomized clinical trials to verify causality between intraoperative opioid administration and long-term outcomes.</p><p>The structure and methodology of this study can be adapted for other exposures and outcomes, and we intend to analyze the effects of nonopioid and regional anesthetic treatment modalities in perioperative pain management. Further follow-up studies in the form of randomized clinical trials are also required to investigate the relationship between the timing of opioid administration and pain-related outcomes.</p><p>The opioid crisis presents a clear need to reduce overall opioid exposure to reduce the risk of dependence. However, the overgeneralization of this imperative to the operating room may have led to worse outcomes. While our results suggest that intraoperative opioids are currently being underdosed on average, in similar fashion we would not want to overgeneralize. Following the recommendation of the American Pain Society<sup><xref rid="soi230031r12" ref-type="bibr">12</xref></sup> that clinicians evaluate each patient on an individual basis, we propose that further work is needed to develop objective measures to support optimal intraoperative opioid administration on a personalized basis.</p></sec></body><back><ref-list id="REF-SOI230031"><title>References</title><ref id="soi230031r1"><label>1</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Florence</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Luo</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Rice</surname><given-names>K</given-names></string-name></person-group>. <article-title>The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017</article-title>. <source>Drug Alcohol Depend</source>. <year>2021</year>;<volume>218</volume>:<elocation-id>108350</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.drugalcdep.2020.108350</pub-id><pub-id pub-id-type="pmid">33121867</pub-id><pub-id pub-id-type="pmcid">PMC8091480</pub-id></mixed-citation></ref><ref id="soi230031r2"><label>2</label><mixed-citation publication-type="webpage"><person-group><string-name name-style="western"><surname>Maclean</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Mallatt</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ruhm</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Simon</surname><given-names>K</given-names></string-name></person-group>. <article-title>Economic studies on the opioid crisis: a review</article-title>. Published November 2020. doi:<pub-id pub-id-type="doi">10.3386/w28067</pub-id></mixed-citation></ref><ref id="soi230031r3"><label>3</label><mixed-citation publication-type="book"><person-group><collab>Substance Abuse Mental Health Services Administration</collab></person-group>. <source>Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health</source>. <publisher-name>National Survey on Drug Use and Health</publisher-name>; <year>2018</year>.</mixed-citation></ref><ref id="soi230031r4"><label>4</label><mixed-citation publication-type="webpage"><person-group><collab>US Centers for Disease Control and Prevention</collab></person-group>. Data Overview&#8212;Opioids. Accessed September 21, 2022. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/opioids/data/index.html" ext-link-type="uri">https://www.cdc.gov/opioids/data/index.html</ext-link></mixed-citation></ref><ref id="soi230031r5"><label>5</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Hah</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Bateman</surname><given-names>BT</given-names></string-name>, <string-name name-style="western"><surname>Ratliff</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Curtin</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>E</given-names></string-name></person-group>. <article-title>Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic</article-title>. <source>Anesth Analg</source>. <year>2017</year>;<volume>125</volume>(<issue>5</issue>):<fpage>1733</fpage>-<lpage>1740</lpage>. doi:<pub-id pub-id-type="doi">10.1213/ANE.0000000000002458</pub-id><pub-id pub-id-type="pmid">29049117</pub-id><pub-id pub-id-type="pmcid">PMC6119469</pub-id></mixed-citation></ref><ref id="soi230031r6"><label>6</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Johnson</surname><given-names>SP</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>KC</given-names></string-name>, <string-name name-style="western"><surname>Zhong</surname><given-names>L</given-names></string-name>, <etal/></person-group>. <article-title>Risk of prolonged opioid use among opioid-na&#239;ve patients following common hand surgery procedures</article-title>. <source>J Hand Surg Am</source>. <year>2016</year>;<volume>41</volume>(<issue>10</issue>):<fpage>947</fpage>-<lpage>957.e3</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jhsa.2016.07.113</pub-id><pub-id pub-id-type="pmid">27692801</pub-id></mixed-citation></ref><ref id="soi230031r7"><label>7</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Jiang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Orton</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Feng</surname><given-names>R</given-names></string-name>, <etal/></person-group>. <article-title>Chronic opioid usage in surgical patients in a large academic center</article-title>. <source>Ann Surg</source>. <year>2017</year>;<volume>265</volume>(<issue>4</issue>):<fpage>722</fpage>-<lpage>727</lpage>. doi:<pub-id pub-id-type="doi">10.1097/SLA.0000000000001780</pub-id><pub-id pub-id-type="pmid">27163960</pub-id><pub-id pub-id-type="pmcid">PMC5557500</pub-id></mixed-citation></ref><ref id="soi230031r8"><label>8</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Kehlet</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Jensen</surname><given-names>TS</given-names></string-name>, <string-name name-style="western"><surname>Woolf</surname><given-names>CJ</given-names></string-name></person-group>. <article-title>Persistent postsurgical pain: risk factors and prevention</article-title>. <source>Lancet</source>. <year>2006</year>;<volume>367</volume>(<issue>9522</issue>):<fpage>1618</fpage>-<lpage>1625</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(06)68700-X</pub-id><pub-id pub-id-type="pmid">16698416</pub-id></mixed-citation></ref><ref id="soi230031r9"><label>9</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Glare</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Aubrey</surname><given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Myles</surname><given-names>PS</given-names></string-name></person-group>. <article-title>Transition from acute to chronic pain after surgery</article-title>. <source>Lancet</source>. <year>2019</year>;<volume>393</volume>(<issue>10180</issue>):<fpage>1537</fpage>-<lpage>1546</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(19)30352-6</pub-id><pub-id pub-id-type="pmid">30983589</pub-id></mixed-citation></ref><ref id="soi230031r10"><label>10</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Vowles</surname><given-names>KE</given-names></string-name>, <string-name name-style="western"><surname>McEntee</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Julnes</surname><given-names>PS</given-names></string-name>, <string-name name-style="western"><surname>Frohe</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Ney</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>van der Goes</surname><given-names>DN</given-names></string-name></person-group>. <article-title>Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis</article-title>. <source>Pain</source>. <year>2015</year>;<volume>156</volume>(<issue>4</issue>):<fpage>569</fpage>-<lpage>576</lpage>. doi:<pub-id pub-id-type="doi">10.1097/01.j.pain.0000460357.01998.f1</pub-id><pub-id pub-id-type="pmid">25785523</pub-id></mixed-citation></ref><ref id="soi230031r11"><label>11</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Kumar</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kirksey</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Duong</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>CL</given-names></string-name></person-group>. <article-title>A review of opioid-sparing modalities in perioperative pain management: methods to decrease opioid use postoperatively</article-title>. <source>Anesth Analg</source>. <year>2017</year>;<volume>125</volume>(<issue>5</issue>):<fpage>1749</fpage>-<lpage>1760</lpage>. doi:<pub-id pub-id-type="doi">10.1213/ANE.0000000000002497</pub-id><pub-id pub-id-type="pmid">29049119</pub-id></mixed-citation></ref><ref id="soi230031r12"><label>12</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Chou</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Gordon</surname><given-names>DB</given-names></string-name>, <string-name name-style="western"><surname>de Leon-Casasola</surname><given-names>OA</given-names></string-name>, <etal/></person-group>. <article-title>Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists&#8217; Committee on Regional Anesthesia, Executive Committee, and Administrative Council</article-title>. <source>J Pain</source>. <year>2016</year>;<volume>17</volume>(<issue>2</issue>):<fpage>131</fpage>-<lpage>157</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpain.2015.12.008</pub-id><pub-id pub-id-type="pmid">26827847</pub-id></mixed-citation></ref><ref id="soi230031r13"><label>13</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Alexander</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Joshi</surname><given-names>GP</given-names></string-name></person-group>. <article-title>Perioperative use of opioids: current controversies and concerns</article-title>. <source>Best Pract Res Clin Anaesthesiol</source>. <year>2019</year>;<volume>33</volume>(<issue>3</issue>):<fpage>341</fpage>-<lpage>351</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bpa.2019.07.009</pub-id><pub-id pub-id-type="pmid">31785719</pub-id></mixed-citation></ref><ref id="soi230031r14"><label>14</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Naik</surname><given-names>BI</given-names></string-name>, <string-name name-style="western"><surname>Kuck</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Saager</surname><given-names>L</given-names></string-name>, <etal/>; <collab>MPOG EOS investigator group</collab></person-group>. <article-title>Practice patterns and variability in intraoperative opioid utilization: a report from the Multicenter Perioperative Outcomes group</article-title>. <source>Anesth Analg</source>. <year>2022</year>;<volume>134</volume>(<issue>1</issue>):<fpage>8</fpage>-<lpage>17</lpage>. doi:<pub-id pub-id-type="doi">10.1213/ANE.0000000000005663</pub-id><pub-id pub-id-type="pmid">34291737</pub-id></mixed-citation></ref><ref id="soi230031r15"><label>15</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Shanthanna</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ladha</surname><given-names>KS</given-names></string-name>, <string-name name-style="western"><surname>Kehlet</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Joshi</surname><given-names>GP</given-names></string-name></person-group>. <article-title>Perioperative opioid administration: a critical review of opioid-free versus opioid-sparing approaches</article-title>. <source>Anesthesiology</source>. <year>2021</year>;<volume>134</volume>(<issue>4</issue>):<fpage>645</fpage>-<lpage>659</lpage>. doi:<pub-id pub-id-type="doi">10.1097/ALN.0000000000003572</pub-id><pub-id pub-id-type="pmid">32991672</pub-id></mixed-citation></ref><ref id="soi230031r16"><label>16</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Egan</surname><given-names>TD</given-names></string-name></person-group>. <article-title>Are opioids indispensable for general anaesthesia?</article-title><source>Br J Anaesth</source>. <year>2019</year>;<volume>122</volume>(<issue>6</issue>):<fpage>e127</fpage>-<lpage>e135</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bja.2019.02.018</pub-id><pub-id pub-id-type="pmid">31104756</pub-id></mixed-citation></ref><ref id="soi230031r17"><label>17</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Kharasch</surname><given-names>ED</given-names></string-name>, <string-name name-style="western"><surname>Avram</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Clark</surname><given-names>JD</given-names></string-name></person-group>. <article-title>Rational perioperative opioid management in the era of the opioid crisis</article-title>. <source>Anesthesiology</source>. <year>2020</year>;<volume>132</volume>(<issue>4</issue>):<fpage>603</fpage>-<lpage>605</lpage>. doi:<pub-id pub-id-type="doi">10.1097/ALN.0000000000003166</pub-id><pub-id pub-id-type="pmid">32058348</pub-id></mixed-citation></ref><ref id="soi230031r18"><label>18</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Murphy</surname><given-names>GS</given-names></string-name>, <string-name name-style="western"><surname>Szokol</surname><given-names>JW</given-names></string-name></person-group>. <article-title>Intraoperative methadone in surgical patients: a review of clinical investigations</article-title>. <source>Anesthesiology</source>. <year>2019</year>;<volume>131</volume>(<issue>3</issue>):<fpage>678</fpage>-<lpage>692</lpage>. doi:<pub-id pub-id-type="doi">10.1097/ALN.0000000000002755</pub-id><pub-id pub-id-type="pmid">31094758</pub-id></mixed-citation></ref><ref id="soi230031r19"><label>19</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Murphy</surname><given-names>GS</given-names></string-name>, <string-name name-style="western"><surname>Avram</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Greenberg</surname><given-names>SB</given-names></string-name>, <etal/></person-group>. <article-title>Postoperative pain and analgesic requirements in the first year after intraoperative methadone for complex spine and cardiac surgery</article-title>. <source>Anesthesiology</source>. <year>2020</year>;<volume>132</volume>(<issue>2</issue>):<fpage>330</fpage>-<lpage>342</lpage>. doi:<pub-id pub-id-type="doi">10.1097/ALN.0000000000003025</pub-id><pub-id pub-id-type="pmid">31939849</pub-id></mixed-citation></ref><ref id="soi230031r20"><label>20</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Joshi</surname><given-names>GP</given-names></string-name>, <string-name name-style="western"><surname>Ogunnaike</surname><given-names>BO</given-names></string-name></person-group>. <article-title>Consequences of inadequate postoperative pain relief and chronic persistent postoperative pain</article-title>. <source>Anesthesiol Clin North Am</source>. <year>2005</year>;<volume>23</volume>(<issue>1</issue>):<fpage>21</fpage>-<lpage>36</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.atc.2004.11.013</pub-id><pub-id pub-id-type="pmid">15763409</pub-id></mixed-citation></ref><ref id="soi230031r21"><label>21</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Gan</surname><given-names>TJ</given-names></string-name></person-group>. <article-title>Poorly controlled postoperative pain: prevalence, consequences, and prevention</article-title>. <source>J Pain Res</source>. <year>2017</year>;<volume>10</volume>:<fpage>2287</fpage>-<lpage>2298</lpage>. doi:<pub-id pub-id-type="doi">10.2147/JPR.S144066</pub-id><pub-id pub-id-type="pmid">29026331</pub-id><pub-id pub-id-type="pmcid">PMC5626380</pub-id></mixed-citation></ref><ref id="soi230031r22"><label>22</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Austin</surname><given-names>PC</given-names></string-name></person-group>. <article-title>An introduction to propensity score methods for reducing the effects of confounding in observational studies</article-title>. <source>Multivariate Behav Res</source>. <year>2011</year>;<volume>46</volume>(<issue>3</issue>):<fpage>399</fpage>-<lpage>424</lpage>. doi:<pub-id pub-id-type="doi">10.1080/00273171.2011.568786</pub-id><pub-id pub-id-type="pmid">21818162</pub-id><pub-id pub-id-type="pmcid">PMC3144483</pub-id></mixed-citation></ref><ref id="soi230031r23"><label>23</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Shafer</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Gregg</surname><given-names>KM</given-names></string-name></person-group>. <article-title>Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer-controlled infusion pump</article-title>. <source>J Pharmacokinet Biopharm</source>. <year>1992</year>;<volume>20</volume>(<issue>2</issue>):<fpage>147</fpage>-<lpage>169</lpage>. doi:<pub-id pub-id-type="doi">10.1007/BF01070999</pub-id><pub-id pub-id-type="pmid">1629794</pub-id></mixed-citation></ref><ref id="soi230031r24"><label>24</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Drover</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Angst</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Valle</surname><given-names>M</given-names></string-name>, <etal/></person-group>. <article-title>Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers</article-title>. <source>Anesthesiology</source>. <year>2002</year>;<volume>97</volume>(<issue>4</issue>):<fpage>827</fpage>-<lpage>836</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00000542-200210000-00013</pub-id><pub-id pub-id-type="pmid">12357147</pub-id></mixed-citation></ref><ref id="soi230031r25"><label>25</label><mixed-citation publication-type="preprint"><person-group><string-name name-style="western"><surname>Williams</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Crespi</surname><given-names>CM</given-names></string-name></person-group>. <article-title>Causal inference for multiple continuous exposures via the multivariate generalized propensity score</article-title>. <source>arXiv</source>. Published online August 31, 2020. doi:<pub-id pub-id-type="doi">10.48550/arXiv.2008.13767</pub-id></mixed-citation></ref><ref id="soi230031r26"><label>26</label><mixed-citation publication-type="data"><person-group><string-name name-style="western"><surname>McLeod</surname><given-names>AI</given-names></string-name></person-group>. Kendall: Kendall rank correlation and Mann-Kendall trend test. Published online March 20, 2022. Accessed October 3, 2022. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://cran.r-project.org/web/packages/Kendall/index.html" ext-link-type="uri">https://cran.r-project.org/web/packages/Kendall/index.html</ext-link></mixed-citation></ref><ref id="soi230031r27"><label>27</label><mixed-citation publication-type="webpage"><person-group><string-name name-style="western"><surname>Therneau</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>Lumley</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Atkinson</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Crowson</surname><given-names>C</given-names></string-name></person-group>. Survival: survival analysis. Published online August 9, 2022. Accessed October 3, 2022. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://cran.r-project.org/web/packages/survival/index.html" ext-link-type="uri">https://cran.r-project.org/web/packages/survival/index.html</ext-link></mixed-citation></ref><ref id="soi230031r28"><label>28</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Vuyk</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mertens</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Olofsen</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Burm</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Bovill</surname><given-names>JG</given-names></string-name></person-group>. <article-title>Propofol anesthesia and rational opioid selection: determination of optimal EC50-EC95 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness</article-title>. <source>Anesthesiology</source>. <year>1997</year>;<volume>87</volume>(<issue>6</issue>):<fpage>1549</fpage>-<lpage>1562</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00000542-199712000-00033</pub-id><pub-id pub-id-type="pmid">9416739</pub-id></mixed-citation></ref><ref id="soi230031r29"><label>29</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Chapman</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Vierck</surname><given-names>CJ</given-names></string-name></person-group>. <article-title>The transition of acute postoperative pain to chronic pain: an integrative overview of research on mechanisms</article-title>. <source>J Pain</source>. <year>2017</year>;<volume>18</volume>(<issue>4</issue>):<fpage>359.e1</fpage>-<lpage>359.e38</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpain.2016.11.004</pub-id><pub-id pub-id-type="pmid">27908839</pub-id></mixed-citation></ref><ref id="soi230031r30"><label>30</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Baharloo</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Principe</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Fillingim</surname><given-names>RB</given-names></string-name>, <etal/></person-group>. <article-title>Slow dynamics of acute postoperative pain intensity time series determined via wavelet analysis are associated with the risk of severe postoperative day 30 pain</article-title>. <source>Anesth Analg</source>. <year>2021</year>;<volume>132</volume>(<issue>5</issue>):<fpage>1465</fpage>-<lpage>1474</lpage>. doi:<pub-id pub-id-type="doi">10.1213/ANE.0000000000005385</pub-id><pub-id pub-id-type="pmid">33591118</pub-id><pub-id pub-id-type="pmcid">PMC8086814</pub-id></mixed-citation></ref><ref id="soi230031r31"><label>31</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Scott</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Ponganis</surname><given-names>KV</given-names></string-name>, <string-name name-style="western"><surname>Stanski</surname><given-names>DR</given-names></string-name></person-group>. <article-title>EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil</article-title>. <source>Anesthesiology</source>. <year>1985</year>;<volume>62</volume>(<issue>3</issue>):<fpage>234</fpage>-<lpage>241</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00000542-198503000-00005</pub-id><pub-id pub-id-type="pmid">3919613</pub-id></mixed-citation></ref><ref id="soi230031r32"><label>32</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Murray</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hagen</surname><given-names>NA</given-names></string-name></person-group>. <article-title>Hydromorphone</article-title>. <source>J Pain Symptom Manage</source>. <year>2005</year>;<volume>29</volume>(<issue>5</issue>)(<supplement>suppl</supplement>):<fpage>S57</fpage>-<lpage>S66</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpainsymman.2005.01.007</pub-id><pub-id pub-id-type="pmid">15907647</pub-id></mixed-citation></ref><ref id="soi230031r33"><label>33</label><mixed-citation publication-type="book"><person-group><string-name name-style="western"><surname>Abi-Aad</surname><given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Derian</surname><given-names>A</given-names></string-name></person-group>. <part-title>Hydromorphone</part-title>. In: <person-group><string-name name-style="western"><surname>Aboubakr</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Abu-Ghosh</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Acharya</surname><given-names>AB</given-names></string-name></person-group>, <person-group><etal/></person-group>, eds. <source>StatPearls</source>. <publisher-name>StatPearls Publishing</publisher-name>; <year>2022</year>.</mixed-citation></ref><ref id="soi230031r34"><label>34</label><mixed-citation publication-type="book"><person-group><string-name name-style="western"><surname>Bailey</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Egan</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Stanley</surname><given-names>T</given-names></string-name></person-group>. <part-title>Intravenous opioid anesthetics</part-title>. In: <person-group><string-name name-style="western"><surname>Miller</surname><given-names>RD</given-names></string-name></person-group>, ed. <source>Anesthesia</source>. <edition>8th ed</edition>. <publisher-name>Saunders</publisher-name>; <year>2015</year>:<fpage>895</fpage>.</mixed-citation></ref><ref id="soi230031r35"><label>35</label><mixed-citation publication-type="book"><person-group><string-name name-style="western"><surname>Butterwoth</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mackey</surname><given-names>D</given-names></string-name>. <string-name name-style="western"><surname>Wasnick</surname><given-names>J</given-names></string-name></person-group>, eds. <part-title>Clinical pharmacology</part-title>. In: <source>Morgan &amp; Mikhail&#8217;s Clinical Anesthesiology</source>. 5th ed. <publisher-name>McGraw Hill</publisher-name>; <year>2013</year>:<fpage>196</fpage>.</mixed-citation></ref><ref id="soi230031r36"><label>36</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Kaafarani</surname><given-names>HMA</given-names></string-name>, <string-name name-style="western"><surname>Eid</surname><given-names>AI</given-names></string-name>, <string-name name-style="western"><surname>Antonelli</surname><given-names>DM</given-names></string-name>, <etal/></person-group>. <article-title>Description and impact of a comprehensive multispecialty multidisciplinary intervention to decrease opioid prescribing in surgery</article-title>. <source>Ann Surg</source>. <year>2019</year>;<volume>270</volume>(<issue>3</issue>):<fpage>452</fpage>-<lpage>462</lpage>. doi:<pub-id pub-id-type="doi">10.1097/SLA.0000000000003462</pub-id><pub-id pub-id-type="pmid">31356279</pub-id></mixed-citation></ref><ref id="soi230031r37"><label>37</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Xie</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Joseph</surname><given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Rudy</surname><given-names>SF</given-names></string-name>, <etal/></person-group>. <article-title>Change in postoperative opioid prescribing patterns for oculoplastic and orbital procedures associated with state opioid legislation</article-title>. <source>JAMA Ophthalmol</source>. <year>2021</year>;<volume>139</volume>(<issue>2</issue>):<fpage>157</fpage>-<lpage>162</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamaophthalmol.2020.5446</pub-id><pub-id pub-id-type="pmid">33300973</pub-id><pub-id pub-id-type="pmcid">PMC7729578</pub-id></mixed-citation></ref><ref id="soi230031r38"><label>38</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Sigal</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Shah</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Onderdonk</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Deaner</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Schlappy</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Barbera</surname><given-names>C</given-names></string-name></person-group>. <article-title>Alternatives to opioid education and a prescription drug monitoring program cumulatively decreased outpatient opioid prescriptions</article-title>. <source>Pain Med</source>. <year>2021</year>;<volume>22</volume>(<issue>2</issue>):<fpage>499</fpage>-<lpage>505</lpage>. doi:<pub-id pub-id-type="doi">10.1093/pm/pnaa278</pub-id><pub-id pub-id-type="pmid">33067993</pub-id></mixed-citation></ref><ref id="soi230031r39"><label>39</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Liu</surname><given-names>VX</given-names></string-name>, <string-name name-style="western"><surname>Eaton</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>DC</given-names></string-name>, <etal/></person-group>. <article-title>Postoperative opioid use before and after enhanced recovery after surgery program implementation</article-title>. <source>Ann Surg</source>. <year>2019</year>;<volume>270</volume>(<issue>6</issue>):<fpage>e69</fpage>-<lpage>e71</lpage>. doi:<pub-id pub-id-type="doi">10.1097/SLA.0000000000003409</pub-id><pub-id pub-id-type="pmid">31232786</pub-id><pub-id pub-id-type="pmcid">PMC7282658</pub-id></mixed-citation></ref><ref id="soi230031r40"><label>40</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Olofsen</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Dahan</surname><given-names>A</given-names></string-name></person-group>. <article-title>Population pharmacokinetics/pharmacodynamics of anesthetics</article-title>. <source>AAPS J</source>. <year>2005</year>;<volume>7</volume>(<issue>2</issue>):<fpage>E383</fpage>-<lpage>E389</lpage>. doi:<pub-id pub-id-type="doi">10.1208/aapsj070239</pub-id><pub-id pub-id-type="pmid">16353918</pub-id><pub-id pub-id-type="pmcid">PMC2750976</pub-id></mixed-citation></ref></ref-list><notes notes-type="supplementary-material" id="note-SOI230031-1"><supplementary-material id="note-SOI230031-1-s" position="float" content-type="local-data" orientation="portrait"><label>Supplement 1.</label><caption><p>eMethods</p><p>eTable 1. Model coefficients for adjusted model</p><p>eTable 2. Most frequent CPT codes in study cohort</p><p>eFigure 1. Forest plot for models without ICD and CPT adjustment</p><p>eFigure 2. Forest plot for interaction models without ICD and CPT adjustment</p><p>eFigure 3. Forest plot for interaction models with ICD and CPT adjustment</p><p>eFigure 4. Forest plot for subgroup analysis in patients with BMI &gt;30 without ICD and CPT adjustment</p><p>eFigure 5. Forest plot for subgroup analysis in patients with BMI &gt;30 with ICD and CPT adjustment</p><p>eFigure 6. Intraoperative opioid administration timing</p><p>eFigure 7. Pain distributions (24h, in hospital)</p><p>eFigure 8. Frequency of pain assessments in each outcome window</p><p>eFigure 9. Intraoperative opioid administration by year</p><p>eFigure 10. Total dosage of intraoperative opioid administration</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jamasurg-e232009-s001.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material position="float" content-type="local-data" orientation="portrait"><label>Supplement 2.</label><caption><p>Data sharing statement</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jamasurg-e232009-s002.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></notes></back></article></pmc-articleset>